Vertex Pharmaceuticals (VRTX) ended the recent trading session at $470.37, demonstrating a +1.88% swing from the preceding day's closing price. The stock's change was more than the S&P 500's daily ...

Vertex Pharmaceuticals (VRTX) shares soared 5.3% in the last trading session to close at $461.68. The move was backed by solid volume with far more shares changing hands than in a normal session.

most new drug applications do not pass Phase 3 trials, with all the positive sentiment tending to fade as capital raising and share dilution take center stage. VRTX has efficiently navigated the ...

Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) on January 31 and set a price target of $515.00. The company’s shares closed last ...

Vertex Pharmaceuticals stock (NASDAQ: VRTX) is trending higher after the ... This data feed is not available at this time.

Vertex Pharmaceuticals (VRTX) ended the recent trading session ... Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch.

Our analysis of options history for Vertex Pharmaceuticals VRTX revealed 10 unusual trades. Delving into the details, we found 20% of traders were bullish, while 80% showed bearish tendencies.

Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.